Lewis Katz School of Medicine
Temple research shows promise in treating deadly form of cancer
Type: In the Media
December 10, 2012
Pre-clinical data shows Angiocidin effective against leukemia
Type: News Story
Angiocidin, a tumor-inhibiting protein discovered by Temple School of Medicine Neuroscience Professor George P. Tuszynski, has been shown in pre-clinical experiments to reduce acute myeloid leukemia cells in mice by almost two-thirds.
December 7, 2012
Student and employee flu shots available for 2012-13
Type: Announcement
Seasonal flu vaccinations will be available for all university students, faculty and staff for the 2012-13 flu season.
September 20, 2012
Temple medical researcher awarded $4.4 million in naval research funding
Type: In the Media
August 20, 2012
State hospitals closed but new treatment options lag behind, report finds
Type: In the Media
July 23, 2012
Puentes de Salud selected for Claneil Foundation's Emerging Leaders Fund
Type: Accolade
July 16, 2012
Sleep deprivation and postpartum weight gain are focus of new study
Type: News Story
Temple researcher Sharon Herring will begin studying whether sleep loss contributes to postpartum weight gain in new mothers. Funded by a $486,000 Clinical Scientist Development Award from the Doris Duke Foundation, the study will focus on urban, low-income mothers, who have the highest levels of obesity in America.
July 10, 2012